Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
885
datasets available to search
ShareScore release 0.9.0
Dataset results
885 results for “cyclophosphamide”
Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer
ClinicalTrials.gov study NCT00352872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis
ClinicalTrials.gov study NCT06000982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT01005979. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma
ClinicalTrials.gov study NCT06918015. IPD Sharing: NO. Countries: 1. Publications: 0.
Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients
ClinicalTrials.gov study NCT06800391. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
ClinicalTrials.gov study NCT00499733. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy
ClinicalTrials.gov study NCT05753618. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide and Alemtuzumab In Lymphoma
ClinicalTrials.gov study NCT03132584. IPD Sharing: NO. Countries: 1. Publications: 0.
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT02488967. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
ClinicalTrials.gov study NCT05849207. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00204659. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory
ClinicalTrials.gov study NCT00010335. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL
ClinicalTrials.gov study NCT07035379. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration
ClinicalTrials.gov study NCT05296317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
ClinicalTrials.gov study NCT00002482. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary
ClinicalTrials.gov study NCT01176799. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01526512. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bort
ClinicalTrials.gov study NCT05470491. IPD Sharing: YES. Countries: 1. Publications: 0.
Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%
ClinicalTrials.gov study NCT03808480. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients
ClinicalTrials.gov study NCT04757337. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.